← back to search

Xin Li

Hebei Medical University · CN
Area of research
Epidemiology · Pathology and Forensic Medicine
Research interest
Research interests include Acute Ischemic Stroke Management, Lymphoma Diagnosis and Treatment, Cerebrovascular and Carotid Artery Diseases, and Viral-associated cancers and disorders.
h-index
19
citations
1,185
works
126
NIH funding
primary concept
email

Recent publications

Cortical thickness correlated with peripheral inflammatory cytokines in amyotrophic lateral sclerosis
Frontiers in Neuroscience 2025cited by 0position: middledoi
Multicenter Phase Ii Study of Moderate Low-Dose Radiotherapy in Indolent Non-Hodgkin Lymphoma: CLCG-iNHL-01 Protocol
Future Oncology 2024cited by 5position: middledoi
Small vessel disease burden predicts functional outcomes in patients with acute ischemic stroke using machine learning
CNS Neuroscience & Therapeutics 2023cited by 20position: middledoi
Eosinophils at diagnosis are elevated in amyotrophic lateral sclerosis
Frontiers in Neurology 2023cited by 7position: middledoi
Arterial Spin Labeling‐Based <scp>MRI</scp> Estimation of Penumbral Tissue in Acute Ischemic Stroke
Journal of Magnetic Resonance Imaging 2022cited by 12position: middledoi
FLAIR vessel hyperintensities predict functional outcomes in patients with acute ischemic stroke treated with medical therapy
European Radiology 2022cited by 10position: middledoi
Impact of the Alberta Stroke Program CT Score subregions on long-term functional outcomes in acute ischemic stroke: Results from two multicenter studies in China
Journal of Translational Internal Medicine 2022cited by 6position: middledoi
Association Between Lipid Accumulation Product and Mild Cognitive Impairment in Patients with Type 2 Diabetes
Journal of Alzheimer s Disease 2020cited by 15position: middledoi
Potential roles of Glucagon-like peptide-1 and its analogues in cognitive impairment associated with type 2 diabetes mellitus
Mechanisms of Ageing and Development 2020cited by 12position: middledoi
A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
Frontiers in Oncology 2019cited by 6position: middledoi
A pilot study of different thrombolytic therapies for acute cerebral infarction due to occlusion of middle cerebral artery
Zhonghua fangshexian yixue zazhi 2012cited by 0position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Shuai Yang · Nanchang University3 papers (2022–2023)Caohui Duan · Chinese PLA General Hospital3 papers (2022–2023)Jinhao Lyu · Chinese PLA General Hospital3 papers (2022–2023)Wen Chen · National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital3 papers (2022–2023)Xin Lou · Guiyang Medical University3 papers (2022–2023)Qi Duan · Chinese PLA General Hospital3 papers (2022–2023)Xiaoyan Wu · Fujian Medical University3 papers (2022–2023)Xueyang Wang · Nanchang University3 papers (2022–2023) · 3 papers (2022–2023)Xiangbing Bian · Chinese PLA General Hospital3 papers (2022–2023) · 3 papers (2022–2023)Yitong Bian · Shanxi Medical University3 papers (2022–2023)Weiting Guo · Shanxi Medical University3 papers (2022–2023)Chenglin Tian · Chinese PLA General Hospital3 papers (2022–2023)Guohua Wang · Harbin Medical University3 papers (2022–2023)Hui Dong · Nanjing University of Chinese Medicine2 papers (2023–2025)Jing Yang · China Three Gorges Corporation (China)2 papers (2023–2025)Yuhong Fu · New York University2 papers (2020–2020)Dan Han · Kunming Medical University2 papers (2022–2022)Ying Wang · Ministry of Agriculture2 papers (2020–2020)